Conventional applicators can’t always reach tumor
Protecting the 4 to 7 million children undergoing CT annually
Early progress in the pursuit of lifesaving apps
'Smart' system builds upon TomoTherapy
Survey also found 20 percent of physicians believe MR uses radiation
System is one-third the standard size and will be used for neurological research
Training Watson to detect conditions before they develop
Percentage increases to 99.5 when combined with pathologist's analysis
A step back from requiring advanced certification
Will process and interpret medical images
Company eyes industry leadership in precision medicine
Reassessing HIPAA compliance in an increasingly data-heavy world
Researchers propose new prognosis index for higher predictive power
A new presence in an emerging market segment
Inks seven year contract for linacs, Gamma Knife and CyberKnife systems
Diminished reimbursement and changing payment models make smart budgeting crucial
Revealing patients who are less likely to benefit from endovascular therapy
Investigating the role of the cerebellum
Yale researchers compared outcomes with conventional blood thinners
May be useful in imaging other organs too
Paving the way to a future without glass slides
'A new window on the brain' may inform drug development
Image the tumor in the same position surgery will be performed in: study
New progress in the war against 'invisible' injuries
Solia S ProMRI comes in three different lengths
'We are planning state-wide suspension of sonography tests'
Ga-68 PSMA has high rate of detection in patients with metastatic prostate tumors
Can contact emergency services, and features wheelchair-dedicated workouts
Mobile PET/CT, syngo.via for SPECT, and exclusive U.S. distro rights for Amyvid
Hospital achieved savings of $478,055
Offloading $3 billion segment could be in the cards: report
With GlucoCEST, researchers aim for safer imaging alternative
The surge to merge in the health care space continues
Forgotten — but not gone
Promoting public-private partnerships for health care solutions
CMS issues update to payment policies and rates under IPPS
Warns of higher costs associated with developing new sources
Limiting kidney exposure while maximizing tumor treatment
Often no symptoms of cardiac issues in these patients
An up-close look at a booming industry